GlaxoSmithKline Gains FDA OK on Two Genetically Targeted Skin Cancer Drugs
GlaxoSmithKline gains FDA OK on two genetically targeted skin cancer drugs
Filed under: dual diagnosis treatment centers
The genetic test approved today is called the THxID BRAF test, a companion diagnostic that will be used to determine if a patient's melanoma cells have the V600E or V600K mutation in the… Continue reading
Dual Diagnosis Treatment, the Alcohol Rehab
Dual Diagnosis Treatment, The Alcohol Rehab – Anyone who enters the Alcohol Rehab Helpline program is in good hands. The treatment is performed by our dedicated team of clinicians and mental health speci…
Operation Vigilant Eagle: Is This Really How We Honor Our Nation's Veterans?
Filed under: dual diagnosis… Continue reading